SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare
Cadila Healthcare
BSE: 532321|NSE: CADILAHC|ISIN: INE010B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 28, 17:00
1129.10
6.4 (0.57%)
VOLUME 7,799
LIVE
NSE
Aug 01, 17:00
1090.75
-25.4 (-2.28%)
VOLUME 102,142
News on Cadila Healthcare
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Cadila Healthcare; target of Rs 1205: Motilal Oswal

6.05 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Cadila Healthcare and has recommended buy rating on the stock with a target of Rs 1205 in its July 30, 2014 research repor...

Accumulate Cadila Healthcare; tgt of Rs 1309: Dolat Capital

4.22 pm | 01 Aug 2014 |  Source: Moneycontrol.com

Dolat Capital is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 1309 in its July 30, 2014 researc...

Hold Cadila Healthcare; target of Rs 1059: ICICIdirect

1.44 pm | 01 Aug 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Cadila Healthcare with a target price of Rs 1059, in its research report dated July 31, 2014....

Top buzzing stocks to trade on July 31 

1.58 pm | 31 Jul 2014 |  Source: CNBC-TV18

Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today - IRB Infra, KEC International, Monsanto, Talwalkars, Cadila, Astra Micr...

Buy SKS Micro, Bharat Forge, Cadila Health: Dharmesh Kant 

1.36 pm | 31 Jul 2014 |  Source: CNBC-TV18

According to Dharmesh Kant of India Nivesh Securities, one may buy Cadila Healthcare for a target of Rs 1,200 and Exide Industries for a target of Rs ...

FDA raises concern over drug production process at Cadila

1.28 pm | 31 Jul 2014 |  Source: Reuters

The FDA has not expressed concerns over the entire facility, said the sources. The US agency communicated its concern to Cadila in a Form 483, a lette...

Dr Reddy's, Lupin, Glenmark top pharma bets: Nomura 

11.25 am | 31 Jul 2014 |  Source: CNBC-TV18

"We have a buy recommendation on both Sun Pharma and Ranbaxy at this point," Saion Mukherjee, research analyst Nomura said....

Bull's Eye: India Cements, IRB Infra, Cadila Health, SKS 

9.04 am | 31 Jul 2014 |  Source: CNBC-TV18

Vishal Malkan, malkansview.com advises buying India Cements for a target price of Rs 110 and Adani Enterprises for a target price of Rs 450....

Cadila Health Q1 profit up 23% to Rs 240 cr led by US sales

3.06 pm | 30 Jul 2014 |  Source: Moneycontrol.com

Consolidated revenue jumped 25.2 percent to Rs 2,050 crore in the quarter ended June 2014 from Rs 1,637 crore in same quarter last year. "Sales growth...

Stocks in news: ITC, L&T, Bharti, Tata Steel, Ranbaxy, IDFC

8.26 am | 30 Jul 2014 |  Source: CNBC-TV18

ITC | Bharti Airtel | Larsen and Toubro | Sesa Sterlite | Ranbaxy Labs | Torrent Power | Dr Reddy's Labs | Tata Steel | Petronet LNG | Tata Global | S...

Cadila Healthcare Q1 profit may jump 23% on strong revenue

3.16 pm | 29 Jul 2014 |  Source: CNBC-TV18

Analysts expect total formulation growth of over 35 percent Y-o-Y and domestic formulation growth of 10 percent that may be impacted by new drug polic...

Buy Hathway Cable, Cadila Health, Wockhardt: AK Prabharkar 

12.40 pm | 23 Jul 2014 |  Source: CNBC-TV18

AK Prabharkar, Independent Advisor recommends buying Essel Propack for a target of Rs 113.40 and Wockhardt for a target of Rs 673....

How new price control list impacts Indian pharma cos

10.42 am | 23 Jul 2014 |  Source: Moneycontrol.com

With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to c...

Bull's Eye: Buy ICICI Bank, Biocon, Cadila Healthcare 

8.41 am | 23 Jul 2014 |  Source: CNBC-TV18

AK Prabharkar, Independent Advisor advises buying Hathway Cable for a target price of Rs 348 and Cadila Healthcare for a target price of Rs 1,144....

Stocks in news: IDFC, ONGC, TCS, CMC, Tech Mahindra, MCX

8.20 am | 17 Jul 2014 |  Source: CNBC-TV18

IDFC | ONGC | Mahindra and Mahindra | TCS | Bajaj Auto | Kolte-Patil Developers | Adani Enterprises | Natco Pharma | Tech Mahindra | J Kumar Infraproj...

Sharekhan positive on pharma; prefers Aurobindo, Torrent

7.03 pm | 15 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its report on pharma sector. The research firm remains positive on the pharmaceutical sector and maintain buy rating on Au...

Anti-diabetes, cardiovascular drugs to get upto 35% cheaper 

4.45 pm | 14 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

See 2% EBITDA impact on pharma pricing expansion: Religare 

9.47 am | 14 Jul 2014 |  Source: CNBC-TV18

Arvind Bothra, vice president, Religare, says that while the pricing isn't as much worrying as the ad hoc expansion of the price control which is a da...

Prefer Aurobindo, Cadila, Divis, Torrent Pharma: Sharekhan

1.29 pm | 10 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its Q1FY2015 pharma earnings preview. According to the research firm, Aurobindo Pharma, Cadila Healthcare, Divis Laborator...

1 2 3
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.